Immediate Impact

51 standout
Sub-graph 1 of 19

Citing Papers

Chronic kidney disease
2025 Standout
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
2025 Standout
2 intermediate papers

Works of Chieh‐Li Yen being referenced

Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use With Mortality Among Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease
2022

Author Peers

Author Last Decade Papers Cites
Chieh‐Li Yen 116 90 39 79 43 346
Sheila Bermejo 154 80 38 77 29 349
Amin Roshdy Soliman 104 89 30 88 50 389
Tao Han Lee 157 75 39 48 27 386
Konstantinos Leivaditis 160 71 28 45 31 394
Enrique Luna 171 65 36 44 49 393
Swetha Rani Kanduri 103 64 16 36 46 332
Carlo Feletti 233 88 35 36 28 410
Mustafa Balal 127 69 45 32 66 346
Agnès Räkel 151 88 60 52 23 398
Lajos Zsom 145 80 52 47 39 359

All Works

Loading papers...

Rankless by CCL
2026